| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IGHG3 |
P01860
|
immunoglobulin heavy constant gamma 3 (G3m marker)
|
|
|
0.513 |
0.769 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| CYTB |
P00156
|
cytochrome b
|
|
|
0.529 |
0.808 |
| RNR2 |
Q8IVG9
|
l-rRNA
|
|
|
0.603 |
0.692 |
| TRNL1 |
|
tRNA
|
|
|
0.534 |
0.731 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| H4C14 |
P62805
|
H4 clustered histone 14
|
|
|
0.541 |
0.692 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| NANS |
Q9NR45
|
N-acetylneuraminate synthase
|
Enzyme
|
|
0.545 |
0.692 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| LPAL2 |
Q16609
|
lipoprotein(a) like 2, pseudogene
|
Enzyme
|
|
0.626 |
0.731 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| MIRLET7B |
|
microRNA let-7b
|
|
|
0.493 |
0.769 |
| MIR100 |
|
microRNA 100
|
|
|
0.521 |
0.846 |